[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 34.204.191.0. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 1,210
Citations 0
Original Investigation
February 5, 2020

Safety and Efficacy of Exposure-Based Risk Reduction Through Family Therapy for Co-occurring Substance Use Problems and Posttraumatic Stress Disorder Symptoms Among Adolescents: A Randomized Clinical Trial

Author Affiliations
  • 1Department of Psychiatry & Behavioral Sciences, National Crime Victims Research & Treatment Center, Medical University of South Carolina, Charleston
  • 2Adolescent Behavioral Health Research Program, Department of Psychiatry, Indiana University School of Medicine, Indianapolis
  • 3Oregon Social Learning Center, Eugene
  • 4Dee Norton Child Advocacy Center, Charleston, South Carolina
JAMA Psychiatry. Published online February 5, 2020. doi:10.1001/jamapsychiatry.2019.4803
Key Points

Question  Is exposure-based risk reduction through family therapy a safe and efficacious treatment compared with treatment as usual for adolescents with co-occurring substance use problems and posttraumatic stress disorder symptoms?

Findings  In this randomized clinical trial that included 124 adolescents aged 13 to 18 years who were followed up 18 months after baseline, greater reductions in substance-using days, marijuana use, and polysubstance use, as well as posttraumatic stress disorder avoidance and hyperarousal symptoms, were observed among participants in the risk reduction through family therapy condition over time.

Meaning  For adolescents who have substance use problems and posttraumatic stress disorder symptoms, an exposure-based treatment for posttraumatic stress disorder symptoms that incorporates substance abuse interventions may yield the best long-term outcomes for these problems.

Abstract

Importance  No empirically supported treatments have been evaluated to address co-occurring substance use problems (SUP) and posttraumatic stress disorder (PTSD) symptoms among adolescents in an integrative fashion. This lack is partially owing to untested clinical lore suggesting that delivery of exposure-based PTSD treatments to youth with SUP might be iatrogenic.

Objective  To determine whether an exposure-based, integrative intervention for adolescents with SUP and PTSD symptoms—risk reduction through family therapy (RRFT)—resulted in improved outcomes relative to a treatment-as-usual (TAU) control condition consisting primarily of trauma-focused cognitive behavioral therapy.

Design, Setting, and Participants  This randomized clinical trial enrolled 124 participants who were recruited from November 1, 2012, through January 30, 2017. Adolescents (aged 13-18 years) who engaged in nontobacco substance use at least once during the past 90 days, experienced at least 1 interpersonal traumatic event, and reported 5 or more PTSD symptoms were enrolled. Blinded assessments were collected at baseline and at 3, 6, 12, and 18 months after baseline. Recruitment and treatment took place in community-based child advocacy centers in the Southeastern United States. Data were analyzed from August 2 through October 4, 2018, and were based on intention to treat.

Interventions  Participants were randomized to receive RRFT (n = 61) or TAU (n = 63).

Main Outcomes and Measures  Primary outcomes focused on number of nontobacco substance–using days measured with the timeline follow-back method and PTSD symptom severity using the UCLA (University of California, Los Angeles) PTSD Reaction Index for DSM-IV completed by adolescents and caregivers. Secondary outcomes focused on marijuana, alcohol, and polysubstance use and PTSD criterion standard (re-experiencing, avoidance, and hyperarousal) symptom severity.

Results  In all, 124 adolescents (mean [SD] age, 15.4 [1.3] years; 108 female [87.1%]) were randomized. For primary outcomes relative to TAU, RRFT yielded significantly greater reductions in substance-using days from baseline to month 12 (event rate [ER], 0.28; 95% CI, 0.12-0.65) and month 18 (ER, 0.10; 95% CI, 0.04-0.24). Significant reductions in PTSD symptoms were observed within groups for RRFT from baseline to months 3 (β = −9.25; 95% CI, −12.95 to −5.55), 6 (β = −16.63; 95% CI = −20.40 to −12.87), 12 (β = −17.51; 95% CI, −21.62 to −13.40), and 18 (β = −19.02; 95% CI, −23.07 to −14.96) and for TAU from baseline to months 3 (β = −9.62; 95% CI, −13.16 to −6.08), 6 (β = −13.73; 95% CI, −17.43 to −10.03), 12 (β = −15.53; 95% CI, −19.52 to −11.55), and 18 (β = −13.88; 95% CI, −17.69 to −10.09); however, between-group differences were not observed.

Conclusions and Relevance  In this study, RRFT and TAU demonstrated within-group improvements in SUP and PTSD symptoms, with greater improvement for substance use and PTSD avoidance and hyperarousal symptoms among adolescents randomized to RRFT compared with TAU. No evidence of the worsening of SUP was observed in either condition. These results suggest that this exposure-based treatment is safe, feasibly delivered by community-based clinicians, and offers an effective approach to inform clinical practice.

Trial Registration  ClinicalTrials.gov Identifier: NCT01751035

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×